A newly developed laboratory tool can, within hours, help to identify specific viruses which can be used to destroy variants ...

Moreover, when that mutant cell replicates, it will pass on its resistant ... and your physician will have to prescribe a different drug to combat it. MRSA: The Spread of Drug Resistance In ...

The study is published in the journal Science. Bacteria, such as MRSA, have mesh like cell walls around them that require ...

In a recent publication in Cell Reports Medicine, a collaborative research team led by Chen-Yu Zhang and Huan Wang at Nanjing ...

A scanning electron micrograph of methicillin-resistant Staphylococcus aureus bacteria, or MRSA (in yellow), surrounding a dead human white blood cell (in red ...

Antibiotic resistance has become an increasing problem in hospitals, rendering a slew of formerly effective antibiotics useless against certain deadly strains of bacteria, such as ...

Current decolonization methods for methicillin-resistant Staphylococcus aureus (MRSA) face several challenges, including resistance development or microbiome disruption. Hypharm GmbH has presented ...

Multidrug-resistant bacteria pose a major threat to human health. Manipulation of bacterial genes at the transcriptional level is a potential strategy to fight antibiotic-resistant bacterial ...

As with penicillin, only a year passed after this semi-synthetic penicillin was released before methicillin-resistant Staph aureus (MRSA) was reported. Initially, MRSA only appeared in hospitals ...

aureus, including hard-to-treat infections caused by methicillin-resistant strains (MRSA), said Basilea ... Neurotech's cell therapy gets FDA nod for eye disorder MacTe... Neurotech Pharma's ...

Given the growing antibiotic resistance crisis, novel ways to target bacterial infections are becoming increasingly important. One potential strategy is to manipulate bacterial genes at the ...

Basilea Pharmaceutica has cited its “stringent risk-return criteria” as a reason for not taking up its option to bring a MRSA antibiotic into clinical development. Basilea secured the license ...